From Drug Discovery and Development A new class of therapeutics, known as recombinant attenuated Salmonella vaccines (RASV), holds potential in the fight against fatal diseases including hepatitis B, tuberculosis, cholera, typhoid fever, AIDS, and pneumonia. Qingke Kong and his colleagues at the Biodesign Institute at Arizona State University, have developed a technique to make such […]